Catherine C. Turkel - Aug 12, 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Stock symbol
LEXX
Transactions as of
Aug 12, 2024
Transactions value $
$5,008
Form type
4
Date filed
8/13/2024, 10:55 AM
Previous filing
Jul 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $5.01K +1.6K +106.67% $3.13 3.1K Aug 12, 2024 Direct
holding LEXX common shares 1.5K Aug 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 3.4K Aug 12, 2024 Common Shares 3.4K $3.04 Direct
holding LEXX Stock Options 5K Aug 12, 2024 Common Shares 1.6K $1.96 Direct
holding LEXX Stock Options 10K Aug 12, 2024 Common Shares 5K $0.87 Direct
holding LEXX Stock Options 15K Aug 12, 2024 Common Shares 5K $2.36 Direct
holding LEXX Stock Options 27K Aug 12, 2024 Common Shares 12K $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.